Single dose study of ABBV-7828 in healthy adults
This study tests a single dose of an investigational drug called ABBV-7828 in healthy adults to see how the body handles it and how food affects it. Participation may help determine the safety and dosing for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- Your body mass index (BMI) must be between 18.0 and 32.0 kg/m².
- You must be in generally good health with no significant medical conditions.
- Your heart rhythm test (ECG) must be normal, with no signs of heart block or prolonged QT interval.
- You must not have any significant allergies to medications or food, or any conditions affecting digestion or absorption.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called ABBV-243 in healthy adults to see if it is safe and how the body processes it. Participation helps researchers understand the drug before studying it in people with a disease.
This early-stage trial tests how the body handles a new experimental drug called ABBV-1451, given as either an infusion (IV drip) or injection. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in people with medical conditions.
This trial studies a new drug called ABBV-859 in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
This study tests a new drug called ABBV-313 in healthy adults to see if it is safe and how the body handles it. You will receive either a single injection or infusion, or multiple doses, to help researchers understand its effects.
This trial tests an experimental oral drug (called ABBV-1162) in healthy adults to see how the body handles it and to check for any side effects. It is one of the first steps in testing a new medicine.
This trial tests a new experimental drug (ISM4808) in healthy adults to see how safe it is and how the body handles it. It may help researchers learn if the drug is promising for future treatments.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.